Vimarsana
Biggest News Aggregation in the World

16383l10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 16383l10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 16383l10 Today - Breaking & Trending Today

Zurcher Kantonalbank Zurich Cantonalbank Trims Stock Position in ChemoCentryx, Inc. (NASDAQ:CCXI) - Vimarsana News

Zurcher Kantonalbank Zurich Cantonalbank Trims Stock Position in ChemoCentryx, Inc. (NASDAQ:CCXI)

Zurcher Kantonalbank Zurich Cantonalbank lessened its position in shares of ChemoCentryx, Inc. (NASDAQ:CCXI – Get Rating) by 16.9% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,919 shares of the biopharmaceutical company’s stock after selling 1,615 shares during the quarter. Zurcher Kantonalbank Zurich […]

ChemoCentryx, Inc. (NASDAQ:CCXI) Receives Average Rating of "Buy" from Brokerages - Vimarsana News

ChemoCentryx, Inc. (NASDAQ:CCXI) Receives Average Rating of "Buy" from Brokerages

Shares of ChemoCentryx, Inc. (NASDAQ:CCXI – Get Rating) have been given a consensus rating of “Buy” by the eight brokerages that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, five have given a buy rating and one has assigned a […]

Analysts Set ChemoCentryx, Inc. (NASDAQ:CCXI) Price Target at $75.00 - Vimarsana News

Analysts Set ChemoCentryx, Inc. (NASDAQ:CCXI) Price Target at $75.00

ChemoCentryx, Inc. (NASDAQ:CCXI – Get Rating) has earned an average recommendation of “Buy” from the eight analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, five have issued a buy recommendation and one has given a strong buy […]

ChemoCentryx, Inc. (NASDAQ:CCXI) Given Consensus Rating of "Buy" by Brokerages - Vimarsana News

ChemoCentryx, Inc. (NASDAQ:CCXI) Given Consensus Rating of "Buy" by Brokerages

ChemoCentryx, Inc. (NASDAQ:CCXI – Get Rating) has received an average rating of “Buy” from the eight research firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, five have given a buy recommendation and one has given a strong buy […]

ChemoCentryx, Inc. (NASDAQ:CCXI) Receives Average Recommendation of "Buy" from Analysts - Vimarsana News

ChemoCentryx, Inc. (NASDAQ:CCXI) Receives Average Recommendation of "Buy" from Analysts

Shares of ChemoCentryx, Inc. (NASDAQ:CCXI – Get Rating) have been assigned an average recommendation of “Buy” from the eight research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, five have issued a buy recommendation and one […]